aldo-keto reductase family 1 member D1
| UniProt | Protein Name |
|---|---|
| P51857 |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| androgen metabolic process | ||
| androgen metabolic process | ||
| bile acid catabolic process |
| GO Term | Evidence Code | PMID |
|---|---|---|
| alditol:NADP+ 1-oxidoreductase activity | ||
| aldo-keto reductase (NADP) activity | ||
| steroid binding | ||
| protein binding | ||
| steroid dehydrogenase activity |
| Gene Ontology |
|---|
| alditol |
| oxidoreductase activity |
| InterPro |
|---|
| Aldo-keto reductase |
| Aldo/keto reductase, conserved site |
| NADP-dependent oxidoreductase domain superfamily |
| NADP-dependent oxidoreductase domain |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0111069 | congenital bile acid synthesis defect 2 |
| HPO ID | HPO Term |
|---|---|
| HP:0002014 | Diarrhea |
| HP:0002240 | Hepatomegaly |
| HP:0002570 | Steatorrhea |
| HP:0002630 | Fat malabsorption |
| HP:0002748 | Rickets |
| HP:0002904 | Hyperbilirubinemia |
| HP:0002908 | Conjugated hyperbilirubinemia |
| HP:0002910 | Elevated circulating hepatic transaminase concentration |
| HP:0003155 | Elevated circulating alkaline phosphatase concentration |
| HP:0003256 | Abnormality of the coagulation cascade |
| Disease ID | Disease Name |
|---|---|
| ORPHA:79303 |
|
| OMIM:235555 |
|
| Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
|---|---|---|---|
| 231 | SGD:S000005646 | ||
| 1109 | SGD:S000005646 | ||
| 1645 | SGD:S000005646 | ||
| 1646 | SGD:S000005646 | ||
| 6718 | Xenbase:XB-GENE-947167 | ||
| 8644 | SGD:S000005646 | ||
| 10327 | SGD:S000005646 | ||
| 11677 | SGD:S000005646 | ||
| 24192 | SGD:S000005646 | ||
| 39304 | FB:FBgn0086254 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025